Smile Digital Health Closes $30 Million in Series B Funding to Progress Innovation as...
TORONTO, January 26, 2023 (Newswire.com) - Smile CDR Inc. (doing business as Smile Digital Health) ("Smile"), a leading FHIR® health data fabric (HDF) and exchange solutions provider, announced the closing of approximately $30 million in Series B growth capital led by existing investors including UPMC Enterprises.
Smile's HDF platform uses industry-leading HDF architecture and ONC-compliant, event-driven FHIR APIs to allow healthcare providers, payers and IT vendors to build secure, composable and scalable data infrastructures. Smile offers a suite of health data, clinical reasoning and marketplace utilities that can support ecosystem-wide data innovation and digital modernization efforts to accelerate healthcare innovation, improve quality of patient care journeys, boost operational efficiencies and reduce costs using intelligent automation implementation strategies.
"Our vision for better global health becomes more achievable when we focus on the inherent value of finding innovative ways to efficiently share and use data. Smile Digital Health has seen significant growth in our platform because it does just this. With transformative solutions that can meet companies' specific needs, we are preparing healthcare providers, payers, researchers and life sciences organizations for a connected future that transcends the capabilities of today's systems," said Duncan Weatherston, Chief Executive Officer at Smile Digital Health.
Smile Digital Health is committed to continuing its advancements in end-to-end interoperability with expanded offerings that enhance the breadth of its data fabric solutions for future digital transformations. The company will use this new round of funding to expand its newly acquired clinical reasoning utility and forward-looking artificial intelligence and machine learning capabilities, further advancing Smile Digital Health as the leader in the field.
"Data fabrics open up many new ways of leveraging and working with health data. We will continue to delve into creating solutions that drive change in healthcare and enable better outcomes for everyone. We will also optimize our solutions, as new regulations and mandates are passed, consistently maintaining offerings that keep payers and providers compliant. When new innovations emerge in the industry, we will look at ways to leverage those in the HDF platform and through our add-on solutions to drive value through data," said Weatherston.
"Successfully raising $30 million in such a challenging capital markets environment is a testament to the strength and desirability of Smile's technological offering and the broad appeal of the vision of its founders," commented Smile Digital Health Chairman, George Rizk.
In 2022, Smile was cited by The Globe and Mail's ranking of Canada's Top Growing Companies. It was also recognized as a 2022 Deloitte Technology Fast 50™ and North America Technology Fast 500™ company for the second year running.
"Smile is a leader in the Health Data Fabric space and is a highly innovative and client-focused company looking to improve healthcare through access to digital information. Its work with Astrata, a company created by UPMC Enterprises, demonstrates Smile's ability to deliver value to many parties in the health ecosystem," said Brent Burns, Executive Vice President at UPMC Enterprises, the venture capital and commercialization arm of leading health system UPMC. "UPMC shares the same passion as Smile for improving healthcare via innovation."
Smile Digital Health has grown rapidly from a 2016 start-up to being a recognized leader in the digital health solutions space, servicing clients across the healthcare spectrum, including many top tier payers and providers across the United States and 18 other countries, as well as research institutions, other health information technology companies and government agencies.
Smile's legal advisors in conjunction with this financing were Davies Ward Phillips & Vineberg LLP.
###
About Smile Digital Health
Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, open framework data fabric and integration platform fuels healthcare's digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate and meaningfully share the health information to power digital transformation. We prepare healthcare providers, payers, researchers and life sciences organizations for a connected future beyond legacy systems, adding new value through intelligent use of information and ultimately delivering better patient outcomes. For more information, visit: SmileDigitalHealth.com.
Contact Information:Victoria Valladolid
Acting Director of Marketing
[email protected]
(877) 537-3343 x 728
Original Source: Smile Digital Health Closes $30 Million in Series B Funding to Progress Innovation as World-Leading Health Data Fabric
ZetrOZ Systems to Showcase New Soft Tissue Healing Innovations sam®x1 and sam®2.0 Technologies at...
LAS VEGAS, January 26, 2023 (Newswire.com) - ZetrOZ Systems will demonstrate the effectiveness of its sam®x1 and sam®2.0 sustained acoustic medicine devices for soft tissue injury therapies at the Las Vegas Regenerative Medicine and MSK Ultrasound Course, the longest-running medical education seminar of its kind, from Jan. 26 to 28 in Las Vegas.
The sam®x1 is the first FDA-cleared pain management device of its kind cleared for everyday, at-home use, and the sam®2.0 is the long-duration solution. Both are wearable pain relief ultrasound devices that inhibit inflammation and accelerate natural healing by stimulating tissue regeneration, increasing circulation, and nutrient exchange in deep musculoskeletal tissue.
The multiple-day educational course, at the Planet Hollywood Resort and Casino, Las Vegas, welcomes hundreds of practitioners as varied as orthopedic surgeons, sports medicine physicians, PM&R physicians, pain management physicians, interventional radiologists, rheumatologists, physical therapists, naturopathic doctors, chiropractors, podiatrists, physician assistants, nurse practitioners, diagnostic sonographers and more.
"The Las Vegas Regenerative Medicine and MSK Ultrasound Course brings in leading physicians and other practitioners who will speak on the administration of ultrasound technology and its many benefits - it offers patients options beyond pain medication or surgery," says Dr. George Lewis, founder and CEO of ZetrOZ Systems. "We're incredibly excited to attend and bring awareness of our innovative pain relief ultrasound device portfolio to more healthcare professionals."
The first day of the program will be dedicated to reviewing scientific updates, new regulations, and best practices of the orthopedic discipline. The last two days will focus on practical ultrasound operation, and ZetrOZ Systems sam®x1 and sam®2.0 will be joining the lineup of medical treatment options available for clinicians to review and apply.
Backed by more than 30 clinical studies, sam® technology was developed with research funded by the National Institutes of Health and the U.S. Department of Defense with the intent of finding new methods of soft tissue healing that reduce the use of narcotics and invasive treatments.
To learn more about sustained acoustic medicine and its effectiveness in soft tissue healing, visit zetroz.com.
About ZetrOZ Systems
ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of +46 patents. The exclusive manufacturer and developer of the sam® product line is designed for the treatment of acute and chronic musculoskeletal conditions.
Contact Information:Buse Kayar
[email protected]
Original Source: ZetrOZ Systems to Showcase New Soft Tissue Healing Innovations sam®x1 and sam®2.0 Technologies at Regenerative and Musculoskeletal Ultrasound Course
Pediatric Resources for Sexual Abuse Prevention Launched by The Mama Bear Effect
Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications
AIMS 2.0 Uses RFID to Bring Next-Day Eyewear Delivery to Independent Eye Doctors
SpendMend Achieves Record Growth and Strategic Investments in 2022
McBee® Advises Revelstoke-Backed The Care Team on the Acquisition of 1st Care Home Health...
The Saint Vinson Eugene Allen Foundation Will Donate $50,000 to Assist Special Needs Families...
